Random forest model used to predict the medical out-of-pocket costs of hypertensive patients

被引:0
|
作者
Kumagai, Narimasa [1 ]
Jakovljevic, Mihajlo [2 ,3 ,4 ]
机构
[1] Seinan Gakuin Univ, Fac Econ, Fukuoka, Japan
[2] TWAS, Sect Social & Econ Sci, UNESCO, Trieste, Italy
[3] Shaanxi Univ Technol, Hanzhong, Peoples R China
[4] Univ Kragujevac, Dept Global Hlth Econ & Policy, Kragujevac, Serbia
关键词
activities of daily living (ADL); exercise; hypertension; Japan; out-of-pocket (OOP) costs; prediction; random forest; PHYSICAL-ACTIVITY; HEALTH; EXPENDITURE; DISEASE; CARE; RISK; AGE;
D O I
10.3389/fpubh.2024.1382354
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Precise prediction of out-of-pocket (OOP) costs to improve health policy design is important for governments of countries with national health insurance. Controlling the medical expenses for hypertension, one of the leading causes of stroke and ischemic heart disease, is an important issue for the Japanese government. This study aims to explore the importance of OOP costs for outpatients with hypertension.Methods To obtain a precise prediction of the highest quartile group of OOP costs of hypertensive outpatients, we used nationwide longitudinal data, and estimated a random forest (RF) model focusing on complications with other lifestyle-related diseases and the nonlinearities of the data.Results The results of the RF models showed that the prediction accuracy of OOP costs for hypertensive patients without activities of daily living (ADL) difficulties was slightly better than that for all hypertensive patients who continued physician visits during the past two consecutive years. Important variables of the highest quartile of OOP costs were age, diabetes or lipidemia, lack of habitual exercise, and moderate or vigorous regular exercise.Conclusion As preventing complications of diabetes or lipidemia is important for reducing OOP costs in outpatients with hypertension, regular exercise of moderate or vigorous intensity is recommended for hypertensive patients that do not have ADL difficulty. For hypertensive patients with ADL difficulty, habitual exercise is not recommended.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Out-of-Pocket Costs for Patients Undergoing Thyroid Surgery
    Zheng, Feibi
    Huang, Yongmei
    Wright, Jason
    Kuo, Jennifer H.
    ANNALS OF SURGERY, 2022, 276 (06) : E937 - E943
  • [2] Overcoming Barriers to Discussing Out-of-Pocket Costs With Patients
    Riggs, Kevin R.
    Ubel, Peter A.
    JAMA INTERNAL MEDICINE, 2014, 174 (06) : 849 - 850
  • [3] Out-of-pocket costs for psoriasis patients receiving ustekinumab through medical or pharmacy benefits
    Carter, C. T.
    Smith, D. B.
    Denny, L.
    Martin, S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB197 - AB197
  • [4] Out-of-pocket health care costs
    Martin, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 164 (02) : 252 - 252
  • [5] Out-of-pocket prescription costs: A Suggestion
    Sontheimer, RD
    Ellis, UM
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (20) : 2430 - 2430
  • [6] Physician strategies to reduce patients' out-of-pocket prescription costs
    Alexander, GC
    Casalino, LP
    Meltzer, DO
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (06) : 633 - 636
  • [7] Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?
    Bielinski, S. J.
    St Sauver, J. L.
    Olson, J. E.
    Wieland, M. L.
    Vitek, C. R.
    Bell, E. J.
    Mc Gree, M. E.
    Jacobson, D. J.
    McCormick, J. B.
    Takahashi, P. Y.
    Black, J. L.
    Caraballo, P. J.
    Sharp, R. R.
    Beebe, T. J.
    Weinshilboum, R. M.
    Wang, L.
    Roger, V. L.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (01): : 1 - 3
  • [8] Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?
    S J Bielinski
    J L St Sauver
    J E Olson
    M L Wieland
    C R Vitek
    E J Bell
    M E Mc Gree
    D J Jacobson
    J B McCormick
    P Y Takahashi
    J L Black
    P J Caraballo
    R R Sharp
    T J Beebe
    R M Weinshilboum
    L Wang
    V L Roger
    The Pharmacogenomics Journal, 2017, 17 : 1 - 3
  • [9] Out-of-Pocket Costs for Patients with Type 2 Diabetes Mellitus
    Davis, Christian
    Burgen, Emily
    Chen, Guoqing J.
    DIABETES, 2018, 67
  • [10] Characteristics of out-of-pocket costs for cancer patients in Ontario, Canada
    Longo, CJ
    Deber, R
    Fitch, M
    Williams, AP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 791S - 791S